---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-066608"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:28:10.207612+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Candel Therapeutics reduces stockholder meeting quorum threshold to one-third

## Summary
- Board approved amendment to bylaws, effective May 29, 2024.
- Quorum requirement lowered from majority to one-third of shares entitled to vote.
- Amendment applies to all stockholder meetings of Candel Therapeutics, Inc.

## SEC filing metadata
- accession: 0000950170-24-066608
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000095017024066608/0000950170-24-066608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000095017024066608/cadl-20240529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-066608
- JSON: https://secwatch.observer/filing/0000950170-24-066608.json
- Plain text: https://secwatch.observer/filing/0000950170-24-066608.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.